Skip to main content
. 2023 May 26;60(8):1119–1151. doi: 10.1007/s00592-023-02107-x
Population People with type 2 diabetes
Intervention Glucose-lowering therapy
Comparison Glucose-lowering therapy
Outcome HbA1c, hypoglycemia, medium-/long-term adherence, mortality; major cardiovascular events
Setting Outpatient